We are live on
!
Find out more
AA
AlphaMark Advisors Portfolio holdings
AUM
$231M
1-Year Est. Return
19.98%
This Fund
S&P 500
This Quarter
Est. Return
+5.09%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$168M
AUM Growth
+$5.28M
(+3.3%)
Cap. Flow
-$1.1M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
28.41%
Holding
314
New
29
Increased
45
Reduced
71
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.64M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$788K |
| 3 |
Universal Electronics
UEIC
|
+$598K |
| 4 |
ASRT
Assertio
ASRT
|
+$584K |
| 5 |
TAL Education Group
TAL
|
+$557K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$3.81M |
| 2 |
Vaalco Energy
EGY
|
+$945K |
| 3 |
The Ensign Group
ENSG
|
+$787K |
| 4 |
PVH
PVH
|
+$693K |
| 5 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$674K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.79% |
| 2 | Healthcare | 16.33% |
| 3 | Industrials | 9.84% |
| 4 | Consumer Discretionary | 8.38% |
| 5 | Financials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Procter & Gamble
PG
$336B
| $5.47M | 3.26% |
69,579
+4,426
| +7% | +$357K |
|
2
Viatris
VTRS
$20.4B
| $5.26M | 3.13% |
101,946
-1,362
| -1% | -$66.9K |
|
3
EOG Resources
EOG
$79.2B
| $5.11M | 3.05% |
43,755
-1,331
| -3% | -$140K |
|
4
Amgen
AMGN
$208B
| $4.82M | 2.87% |
40,694
-209
| -0.5% | -$24.2K |
|
|
NVO
5
Novo Nordisk
NVO
$208B
| $4.68M | 2.79% |
202,532
-312
| -0.2% | -$6.89K |
|
6
American Express
AXP
$227B
| $4.57M | 2.72% |
48,158
-1,443
| -3% | -$130K |
|
7
Apple
AAPL
$4.54T
| $4.55M | 2.71% |
195,944
-15,904
| -8% | -$338K |
|
|
ANDV
8
DELISTED
Andeavor
ANDV
| $4.44M | 2.65% |
75,665
+16
| +0% | +$882 |
|
|
GMCR
9
DELISTED
KEURIG GREEN MTN INC
GMCR
| $4.43M | 2.64% |
35,589
-1,184
| -3% | -$129K |
|
|
CLR
10
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $4.33M | 2.58% |
54,838
-2,036
| -4% | -$142K |
|
11
Intercontinental Exchange
ICE
$85.6B
| $4.04M | 2.41% |
106,920
+805
| +0.8% | +$31.4K |
|
|
12
Gilead Sciences
GILD
$162B
| $3.88M | 2.31% |
+46,823
| New | +$3.64M |
|
13
Packaging Corp of America
PKG
$21.9B
| $3.71M | 2.21% |
51,899
+639
| +1% | +$43.9K |
|
14
Rockwell Automation
ROK
$53.4B
| $3.64M | 2.17% |
29,049
-560
| -2% | -$69K |
|
15
Jazz Pharmaceuticals
JAZZ
$15.9B
| $3.36M | 2% |
22,825
+1,679
| +8% | +$233K |
|
16
Estee Lauder
EL
$30.4B
| $3.29M | 1.96% |
44,306
-504
| -1% | -$37K |
|
17
Flowserve
FLS
$9.71B
| $3.28M | 1.95% |
44,096
-2,221
| -5% | -$168K |
|
18
McDonald's
MCD
$192B
| $3.28M | 1.95% |
32,528
+410
| +1% | +$41.4K |
|
19
Cirrus Logic
CRUS
$6.53B
| $3.26M | 1.94% |
143,367
-465
| -0.3% | -$10.2K |
|
20
Polaris
PII
$3.82B
| $3.25M | 1.94% |
24,973
+448
| +2% | +$59.3K |
|
21
Amphenol
APH
$198B
| $3.23M | 1.93% |
268,616
-5,816
| -2% | -$69.3K |
|
22
Warner Bros
WBD
$65.9B
| $3.17M | 1.89% |
83,623
+175
| +0.2% | +$6.88K |
|
|
HOT
23
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $3.12M | 1.86% |
38,640
-112
| -0.3% | -$8.8K |
|
24
Oracle
ORCL
$374B
| $3.08M | 1.84% |
76,057
-384
| -0.5% | -$15.8K |
|
25
Akamai
AKAM
$16.7B
| $3.01M | 1.79% |
49,266
+59
| +0.1% | +$3.28K |
|
Similar funds
AJ
MWS
LHR
HPFG
GWM
KC
SL
CSWM
AlphaMark Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, AlphaMark Advisors held 314 positions worth $168M, up 3.3% from $162M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
AlphaMark Advisors's Q2 2014 filing shows 29 new, 45 increased, 71 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 46,823 shares worth $3.88M. The largest sale was Perrigo, an estimated $3.81M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.
- AlphaMark Advisors's largest Q2 2014 buy was Gilead Sciences: 46,823 shares worth $3.88M.
- AlphaMark Advisors added most to Momenta Pharmaceuticals, Inc. in Q2 2014, an estimated $788K increase.
- AlphaMark Advisors's biggest Q2 2014 reduction was Perrigo, cutting an estimated $3.81M.
- AlphaMark Advisors fully exited Vaalco Energy in Q2 2014, selling an estimated $945K.
- AlphaMark Advisors's ten largest holdings make up 28% of its $168M portfolio in Q2 2014.
- AlphaMark Advisors opened 29 new positions and closed 9 in Q2 2014.
- AlphaMark Advisors's portfolio value rose 3.3% quarter-over-quarter to $168M.
Based on AlphaMark Advisors's 13F filing for Q2 2014, filed 29 Jul 2014.